Veravas

Veravas

Private
Austin, TexasHealthcare & Life Scienceshttps://veravas.com/

Last Round

Accelerator

Jun 5, 2025

Total Funding Raised

$4M

Momentum Score

50 /100

Company Overview

Veravas is a diagnostics technology company that provides a platform to manage sample preparation and diagnostic solutions for early disease detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

Alzheimer's detectionearly disease detectionbiomarker purificationliquid biopsysample preparationblood test for Alzheimer'slow-abundance biomarkersbiomarker enrichmentdiagnostic assaysmagnetic nanobeadslaboratory-developed testLDTneurodegenerative disease diagnosticsresearch-use-onlyRUOdiagnostic reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veravas Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Veravas Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
Convertible DebtFeb 19, 2020

Key People

Founding team and executive leadership

Joshua Soldo

Chief Scientific Officer & Co-Founder

Founding Team

John Forrest

Founder And CEO, Founder And Executive Chairman

Founding Team

Nancy Carson

Chief Operating Officer

Executive Team

Veravas Investors

Notable investors and investment history

InvestorRounds
MedTech InnovatorAccelerator
American Heart Association VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 287% MoM.

  • Jan 21, 2026

    Monthly visitors increased 53% MoM.

Veravas Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Veravas Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Veravas's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range20
Year Founded2017
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.